Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

Arix Bioscience PLC
LSE:ARIX

Watchlist Manager
Arix Bioscience PLC Logo
Arix Bioscience PLC
LSE:ARIX
Watchlist
Price: 142 GBX
Market Cap: £183.7m
Write Note Create Alert Ask AI

Arix Bioscience PLC
Investor Relations

Arix Bioscience Plc is a global venture capital company. The firm is a holding company that is focused on generating value from the development and commercialization of technologies and discoveries. The firm's principal activity is to source, finance and develop healthcare and life science businesses across the world. The firm focuses on acquiring interests in, and provide operational oversight to, healthcare and life science businesses with which it partners in the healthcare and life science sector. The Company’s portfolio includes Harpoon Therapeutics, Inc. (HARP), Artios Pharma Ltd (Artios), Aura Biosciences Inc (Aura), LogicBio Therapeutics, Inc. (LOGC). The firm's subsidiaries include Depixus SAS (EUR), Quench Bio, Inc., Stipe Therapeutics Aps and Twelve Bio Aps.

Show more
Loading
ARIX
FTSE All Share Index
1Y 3Y 5Y 10Y 15Y 20Y
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Tom Davidson
COO & CFO
No Bio Available
Ms. Laura Craig
Investor Relations Officer
No Bio Available
Dr. Tassos Konstantinou Ph.D.
Managing Director
No Bio Available
Ms. Jade Fletcher
Financial Controller
No Bio Available
Mr. Felix Breyer Ph.D.
Associate
No Bio Available
Mr. Roy Bartel-Taverner M.D.
Analyst
No Bio Available

Contacts

Address
London
Duke Street House, 50 Duke Street
Contacts
+442072901050.0
arixbioscience.com
sparklesyt

See Also

Summary
ARIX intrinsic value, competitors valuation, and company profile.
DCF Valuation
ARIX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ARIX stock valuation using valuation multiples.
Wall Street Estimates
ARIX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ARIX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 317,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.